Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17,010 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer.
Takeda K, Kawasaki Y, Sakayauchi T, Takahashi C, Katagiri Y, Tanabe T, Ishikawa Y, Fujimoto K, Kubozono M, Kozumi M, Abe K, Narazaki K, Tasaka S, Umezawa R, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Ito A, Jingu K. Takeda K, et al. Among authors: yamamoto t. Asia Ocean J Nucl Med Biol. 2023;11(1):13-22. doi: 10.22038/AOJNMB.2022.67136.1468. Asia Ocean J Nucl Med Biol. 2023. PMID: 36619192 Free PMC article.
Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.
Takeda K, Takai Y, Narazaki K, Mitsuya M, Umezawa R, Kadoya N, Fujita Y, Sugawara T, Kubozono M, Shimizu E, Abe K, Shirata Y, Ishikawa Y, Yamamoto T, Kozumi M, Dobashi S, Matsushita H, Chida K, Ishidoya S, Arai Y, Jingu K, Yamada S. Takeda K, et al. Among authors: yamamoto t. Radiat Oncol. 2012 Jul 6;7:105. doi: 10.1186/1748-717X-7-105. Radiat Oncol. 2012. PMID: 22770471 Free PMC article.
Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.
Jingu K, Matsushita H, Takeda K, Umezawa R, Takahashi C, Sugawara T, Kubozono M, Abe K, Tanabe T, Shirata Y, Yamamoto T, Ishikawa Y, Nemoto K. Jingu K, et al. Among authors: yamamoto t. BMC Cancer. 2012 Nov 22;12:542. doi: 10.1186/1471-2407-12-542. BMC Cancer. 2012. PMID: 23171077 Free PMC article. Clinical Trial.
Dosimetric impact of 4-dimensional computed tomography ventilation imaging-based functional treatment planning for stereotactic body radiation therapy with 3-dimensional conformal radiation therapy.
Kadoya N, Cho SY, Kanai T, Onozato Y, Ito K, Dobashi S, Yamamoto T, Umezawa R, Matsushita H, Takeda K, Jingu K. Kadoya N, et al. Among authors: yamamoto t. Pract Radiat Oncol. 2015 Sep-Oct;5(5):e505-e512. doi: 10.1016/j.prro.2015.03.001. Epub 2015 Apr 18. Pract Radiat Oncol. 2015. PMID: 25899221
Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
Yamamoto T, Kadoya N, Shirata Y, Kaneta T, Koto M, Umezawa R, Ishikawa Y, Kubozono M, Sugawara T, Matsushita H, Abe K, Takeda K, Jingu K. Yamamoto T, et al. Ann Nucl Med. 2015 Oct;29(8):666-73. doi: 10.1007/s12149-015-0991-5. Epub 2015 Jun 4. Ann Nucl Med. 2015. PMID: 26040413
Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols.
Umezawa R, Jingu K, Matsushita H, Sugawara T, Kubozono M, Yamamoto T, Ishikawa Y, Kozumi M, Takahashi N, Katagiri Y, Kadoya N, Takeda K, Ariga H, Nemoto K, Yamada S. Umezawa R, et al. Among authors: yamamoto t. BMC Cancer. 2015 Oct 27;15:813. doi: 10.1186/s12885-015-1836-2. BMC Cancer. 2015. PMID: 26506988 Free PMC article.
17,010 results
You have reached the last available page of results. Please see the User Guide for more information.